Pfizer Recalls Dextrose Injection Due to Incorrect Expiration Date Labeling
Pfizer is recalling 77,100 syringes of 25% Dextrose Injection because the expiration date printed on the syringes is incorrect.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of the product could cause temporary or medically reversible health consequences. The hazard is a labeling error regarding expiration dates, which is a moderate risk compared to active contamination or structural defects.
Plain-English summary
Pfizer Inc. is recalling 77,100 syringes of 25% Dextrose Injection, USP. The product is a prescription-only intravenous medication manufactured by Hospira, Inc. The specific lot number is 80-292-EV.
The recall was initiated due to a labeling error. The expiration date printed on the syringes is August 1, 2021, which is incorrect. The date printed on the carton is August 1, 2019. This discrepancy may lead to the use of expired medication.
The affected product was distributed nationwide within the United States, including Puerto Rico. Healthcare providers and patients should check their inventory for this specific lot number and discontinue use if found. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- DEXTROSE (DEXTROSE MONOHYDRATE)
- Brand
- DEXTROSE
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injection
- Affected units
- 77,100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 80-292-EV
Distribution
Related recalls
Same brand · DEXTROSE
- SevereDextrose Injection USP recalled due to sterility assurance concerns
FDA (Drugs) · 2026-04-29
- HighFresenius Kabi 50 mL dextrose injection bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 5% dextrose injection bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 100 mL dextrose injection bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- SeverePfizer 5% Dextrose Injection Recalled for Potential Bag Leakage
FDA (Drugs) · 2021-12-08
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- SevereHospira Recalls 5% Dextrose Injection Due to Sterility Concerns
FDA (Drugs) · 2015-03-25
- SevereHospira Recalls 70% Dextrose Injection Due to Possible Leaking Bags
FDA (Drugs) · 2013-07-03
- SeverePfizer 5% Dextrose Injection Recalled for Potential Bag Leakage
FDA (Drugs) · 2021-12-08
- LowHospira Recalls Normosol-M Bags With Incorrect Expiration Date Labeling
FDA (Drugs) · 2016-03-02
- HighPfizer Recalls LMD in Dextrose Bags Due to Sterility Concerns
FDA (Drugs) · 2019-10-16